Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026)

Prokidney (PROK) reported Total Non-Current Liabilities of $28.6 million for Q1 2026, down 19.01% year-over-year from $35.3 million in Q1 2025, and down 15.13% quarter-over-quarter from $33.7 million in Q4 2025.

Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Total Non-Current Liabilities data on file, last reported at $28.6 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $28.6 million, down 19.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.6 million (down 19.01% YoY), and the FY2025 annual result was $33.7 million, down 12.87% from the prior year.
  • Total Non-Current Liabilities slipped to $28.6 million in Q1 2026 per PROK's latest filing, from $33.7 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $38.7 million in Q4 2024 and troughed at $11.6 million in Q3 2022.
  • A 5-year average of $26.5 million and a median of $28.6 million in 2026 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities surged 124.18% in 2023, then fell 19.01% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $12.8 million in 2022, then surged by 124.18% to $28.6 million in 2023, then jumped by 35.05% to $38.7 million in 2024, then dropped by 12.87% to $33.7 million in 2025, then fell by 15.13% to $28.6 million in 2026.
  • Business Quant data shows PROK's Total Non-Current Liabilities at $28.6 million in Q1 2026, $33.7 million in Q4 2025, and $32.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Prokidney 259.01 Mn 1.55 Bn - 28.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.61 Mn
Dec 31, 2025 33.71 Mn
Sep 30, 2025 32.31 Mn
Jun 30, 2025 31.78 Mn
Mar 31, 2025 35.32 Mn
Dec 31, 2024 38.69 Mn
Sep 30, 2024 30.55 Mn
Jun 30, 2024 26.23 Mn
Mar 31, 2024 24.16 Mn
Dec 31, 2023 28.65 Mn
Sep 30, 2023 23.10 Mn
Jun 30, 2023 26.78 Mn
Mar 31, 2023 13.75 Mn
Dec 31, 2022 12.78 Mn
Sep 30, 2022 11.56 Mn
Dec 31, 2021 13.38 Mn